健康安全保障リスク指数
INFORM-style aggregation, on 0 to 10, of epidemic and AMR hazard, disease burden and undernutrition against health-system and IHR capacity, each component oriented by its own polarity.
geometric
expert weights · floor 0.1 where geometric
1,000 draws
normalisation, weights, aggregation, imputation
5 components
25 leaf indicators
67% minimum
modelled share ≤ 20%
From indicators to the composite
Shows where an outbreak is likely, where it would land on a vulnerable population and where the system could not contain it; each sub-index stays visible.
- 感染症流行事象の頻度Indicator · IND · 1Average annual number of distinct infectious-disease outbreak events in the country reported by WHO or a regional public-health agency over the latest five years, counting each event once whatever its duration.
- 報告されたコレラ症例(人口 100,000 人あたり)Indicator · IND · /10*5Cholera cases reported to WHO in the year per 100,000 of the mid-year population.
- MRSA による血流感染Indicator · IND · %Share of Staphylococcus aureus bloodstream infections that are methicillin-resistant, among patients with a tested blood sample.
- 第 3 世代セファロスポリン耐性大腸菌(E. coli)による血流感染Indicator · IND · %Share of Escherichia coli bloodstream infections resistant to third-generation cephalosporins, among patients with a tested blood sample.
- 5 歳未満児死亡率Indicator · IND · /10*3Probability, per 1,000 live births, that a child born in the year dies before reaching age five at current age-specific mortality.
- 妊産婦死亡率Indicator · IND · /10*5Deaths of women from pregnancy-related causes during pregnancy or within 42 days of its end, per 100,000 live births, as modelled by the UN inter-agency group.
- 主要な非感染性疾患による早期死亡Indicator · IND · %Probability, in percent, of dying between exact ages 30 and 70 from cardiovascular disease, cancer, diabetes or chronic respiratory disease.
- 結核罹患率Indicator · IND · /10*5Estimated new and relapse tuberculosis cases of all forms per 100,000 population in the year.
- マラリア罹患率Indicator · IND · /10*3Estimated new malaria cases per 1,000 people living in areas at risk of transmission.
- HIV 罹患率Indicator · IND · /10*3New HIV infections in the year per 1,000 uninfected people of all ages.
- 5 歳未満児の発育阻害Indicator · IND · %Share of children under five whose height-for-age is more than two standard deviations below the WHO Child Growth Standards median (modelled estimate).
- 5 歳未満児の消耗症Indicator · IND · %Share of children under five whose weight-for-height is more than two standard deviations below the WHO Child Growth Standards median, from the latest national survey.
- 妊娠可能年齢の女性の貧血Indicator · IND · %Share of women aged 15 to 49 with haemoglobin below the WHO threshold for their pregnancy status, adjusted for altitude and smoking.
- 人口 1,000 人あたり医師数Indicator · IND · /10*3Practising or professionally active medical doctors, generalists and specialists, per 1,000 population.
- 人口 1,000 人あたり看護師・助産師数Indicator · IND · /10*3Nursing and midwifery personnel, professional and associate, per 1,000 population.
- 人口 1,000 人あたり病床数Indicator · IND · /10*3Inpatient beds in public, private, general and specialised hospitals and rehabilitation centres, per 1,000 population.
- UHC サービス・カバレッジ指数Indicator · IND · scoreIndex from 0 to 100 of the average coverage of essential services across reproductive, maternal, newborn and child health, infectious disease, non-communicable disease and service capacity and access.
- DTP3 予防接種率Indicator · IND · %Share of surviving infants who received the third dose of diphtheria-tetanus-pertussis-containing vaccine, as estimated by WHO and UNICEF.
- 麻疹ワクチン 2 回目接種率Indicator · IND · %Share of children who received the second dose of measles-containing vaccine by the nationally recommended age.
- 熟練した医療従事者が立ち会う出産Indicator · IND · %Share of live births attended by a doctor, nurse or midwife trained to manage normal deliveries and refer complications.
- 経常保健支出(GDP 比)Indicator · IND · %Spending on health goods and services consumed in the year, from all financing sources, as a percentage of GDP (SHA 2011).
- IHR 検査能力(SPAR C4)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for national laboratory systems: specimen referral and transport, biosafety, quality and testing for priority pathogens.
- IHR サーベイランス能力(SPAR C5)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for early-warning, event-based and indicator-based surveillance and event verification.
- IHR 健康危機管理能力(SPAR C7)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for emergency risk assessment, preparedness planning, emergency operations and logistics.
- IHR リスク・コミュニケーション能力(SPAR C10)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for risk communication systems, community engagement and management of misinformation in emergencies.
- Epidemic and AMR hazard sub-indexSub-index · SUB · w 1 · 22.2%Composite of outbreak event frequency, reported cholera and resistance among MRSA and E. coli bloodstream infections.
- Disease burden sub-indexSub-index · SUB · w 1 · 22.2%Composite of under-five and maternal mortality, premature non-communicable disease mortality and the incidence of tuberculosis, malaria and HIV.
- Undernutrition sub-indexSub-index · SUB · w 0.5 · 11.1%Composite of child stunting, child wasting and anaemia among women of reproductive age.
- Health-system capacity sub-indexSub-index · SUB · w 1 · 22.2%Composite of doctor, nurse and bed density, UHC service coverage, routine immunisation, skilled birth attendance and health spending.
- IHR operational capacity sub-indexSub-index · SUB · w 1 · 22.2%Composite of the SPAR laboratory, surveillance, health emergency management and risk communication capacity scores.
- 健康安全保障リスク指数Domain index · IDX · geometricINFORM-style aggregation, on 0 to 10, of epidemic and AMR hazard, disease burden and undernutrition against health-system and IHR capacity, each component oriented by its own polarity.
- 人間とシステムの脆弱性Pillar · PILLAR · 8 indicesHow susceptible are people, livelihoods, ecosystems and essential systems to harm when a shock arrives?
- NXS-GRX (canonical data, provenance and risk) Composite RiskComposite · COMPOSITE · four pillarsComposite = (HTE × VUL × MSF × LCC)^(1/4), each pillar on 0–10 floored at 0.1; pillar = expert-weighted geometric mean of its domain indices
Run this index’s own aggregation
Set each component, change the aggregation or the weight uncertainty, and watch the interval, the class probability and each component’s contribution respond.
Treatment, normalisation, weighting, aggregation, uncertainty
- Treatment
- WINSORISE
- Outlier rule
- |skew| > 2, kurtosis > 3.5
- Normalisation
- INFORM 0–10 rescaling
- Imputation
- NONE
- Coverage minimum
- 67% of components
- Modelled share cap
- 20% of weight
- Weighting
- 専門家
- Aggregation
- geometric
- Scale
- 0 to 10
- 不確実性
- 1,000 Monte Carlo runs over normalisation, weights, aggregation, imputation
- Framework basis
- INFORM Risk methodology (geometric dimensions); IHR (2005) monitoring framework; JRC COIN 10-step guide; OECD/JRC Handbook (2008)
5 components, 25 indicators
Epidemic and AMR hazard sub-index w 1
Composite of outbreak event frequency, reported cholera and resistance among MRSA and E. coli bloodstream infections.
| 指標 | 単位 | エビデンス | 出典 | 割合 |
|---|---|---|---|---|
感染症流行事象の頻度IND.HLT.epidemic.outbreak_event_frequency | 1 | Class B | who-disease-outbreak-news, who-weekly-bulletin-afro, africa-cdc-epidemic-intelligence | 40.0% |
報告されたコレラ症例(人口 100,000 人あたり)IND.HLT.epidemic.cholera_cases.p100k | /10*5 | Class B | who-gho, who-cholera-annual-report | 20.0% |
MRSA による血流感染IND.HLT.amr.mrsa_bloodstream | % | Class B | who-glass, who-gho | 20.0% |
第 3 世代セファロスポリン耐性大腸菌(E. coli)による血流感染IND.HLT.amr.ecoli_3gc_bloodstream | % | Class B | who-glass, who-gho | 20.0% |
Disease burden sub-index w 1
Composite of under-five and maternal mortality, premature non-communicable disease mortality and the incidence of tuberculosis, malaria and HIV.
| 指標 | 単位 | エビデンス | 出典 | 割合 |
|---|---|---|---|---|
5 歳未満児死亡率IND.HLT.burden.under5_mortality | /10*3 | Class C | un-igme, wb-wdi, who-gho | 16.7% |
妊産婦死亡率IND.HLT.burden.maternal_mortality | /10*5 | Class C | un-mmeig, wb-wdi, who-gho | 16.7% |
主要な非感染性疾患による早期死亡IND.HLT.burden.ncd_premature_mortality | % | Class C | who-ghe, wb-wdi | 16.7% |
結核罹患率IND.HLT.burden.tb_incidence | /10*5 | Class C | who-global-tb-programme, wb-wdi | 16.7% |
マラリア罹患率IND.HLT.burden.malaria_incidence | /10*3 | Class C | who-world-malaria-report, wb-wdi | 16.7% |
HIV 罹患率IND.HLT.burden.hiv_incidence | /10*3 | Class C | unaids, wb-wdi, who-gho | 16.7% |
Undernutrition sub-index w 0.5
Composite of child stunting, child wasting and anaemia among women of reproductive age.
| 指標 | 単位 | エビデンス | 出典 | 割合 |
|---|---|---|---|---|
5 歳未満児の発育阻害IND.HLT.nutrition.stunting | % | Class C | unicef-who-wb-jme, wb-wdi, who-gho | 33.3% |
5 歳未満児の消耗症IND.HLT.nutrition.wasting | % | Class B | unicef-who-wb-jme, wb-wdi, smart-surveys | 33.3% |
妊娠可能年齢の女性の貧血IND.HLT.nutrition.anaemia_women | % | Class C | who-gho, wb-wdi | 33.3% |
Health-system capacity sub-index w 1
Composite of doctor, nurse and bed density, UHC service coverage, routine immunisation, skilled birth attendance and health spending.
| 指標 | 単位 | エビデンス | 出典 | 割合 |
|---|---|---|---|---|
人口 1,000 人あたり医師数IND.HLT.system.physician_density | /10*3 | Class B | who-nhwa, wb-wdi | 11.1% |
人口 1,000 人あたり看護師・助産師数IND.HLT.system.nurse_midwife_density | /10*3 | Class B | who-nhwa, wb-wdi | 11.1% |
人口 1,000 人あたり病床数IND.HLT.system.hospital_beds | /10*3 | Class B | who-gho, wb-wdi, oecd-health | 11.1% |
UHC サービス・カバレッジ指数IND.HLT.system.uhc_service_coverage | {score} | Class C | who-gho, wb-wdi | 22.2% |
DTP3 予防接種率IND.HLT.system.dtp3_coverage | % | Class C | who-unicef-wuenic, wb-wdi | 11.1% |
麻疹ワクチン 2 回目接種率IND.HLT.system.mcv2_coverage | % | Class C | who-unicef-wuenic, wb-hnp-stats | 11.1% |
熟練した医療従事者が立ち会う出産IND.HLT.system.skilled_birth_attendance | % | Class B | unicef-who-joint-database, wb-wdi | 11.1% |
経常保健支出(GDP 比)IND.HLT.system.health_expenditure.gdp | % | Class B | who-ghed, wb-wdi | 11.1% |
IHR operational capacity sub-index w 1
Composite of the SPAR laboratory, surveillance, health emergency management and risk communication capacity scores.
| 指標 | 単位 | エビデンス | 出典 | 割合 |
|---|---|---|---|---|
IHR 検査能力(SPAR C4)IND.HLT.security.spar_laboratory | {score} | Class B | who-spar, who-jee | 25.0% |
IHR サーベイランス能力(SPAR C5)IND.HLT.security.spar_surveillance | {score} | Class B | who-spar, who-jee | 25.0% |
IHR 健康危機管理能力(SPAR C7)IND.HLT.security.spar_emergency_management | {score} | Class B | who-spar, who-jee | 25.0% |
IHR リスク・コミュニケーション能力(SPAR C10)IND.HLT.security.spar_risk_communication | {score} | Class B | who-spar, who-jee | 25.0% |
健康
Disease burden, health-system capacity and health-security preparedness.
| Sub-domain | 指標 |
|---|---|
| Disease burden and mortality | 8 |
| Health system capacity | 11 |
| Health security (IHR) | 5 |
| Epidemic and outbreak | 2 |
| Antimicrobial resistance | 2 |
| Nutrition | 3 |
Anchor frameworks (pillar structure and definitions only): WHO GHO; IHR JEE 3rd ed.; IHR SPAR 2nd ed.; SDG 3.
All 31 health indicators
| 指標 | 分野 | Sub-domain | 構成要素 | 単位 | レベル | Crosswalks |
|---|---|---|---|---|---|---|
5 歳未満児死亡率IND.HLT.burden.under5_mortality | HLT | Disease burden and mortality | vulnerability | /10*3 | COUNTRY | WB_WDI SH.DYN.MORT SDG 3.2.1 WHO_GHO MDG_0000000007 |
新生児死亡率IND.HLT.burden.neonatal_mortality | HLT | Disease burden and mortality | vulnerability | /10*3 | COUNTRY | WB_WDI SH.DYN.NMRT SDG 3.2.2 |
妊産婦死亡率IND.HLT.burden.maternal_mortality | HLT | Disease burden and mortality | vulnerability | /10*5 | COUNTRY | WB_WDI SH.STA.MMRT SDG 3.1.1 WHO_GHO MDG_0000000026 |
出生時平均余命IND.HLT.burden.life_expectancy | HLT | Disease burden and mortality | vulnerability | a | COUNTRY | WB_WDI SP.DYN.LE00.IN WHO_GHO WHOSIS_000001 |
主要な非感染性疾患による早期死亡IND.HLT.burden.ncd_premature_mortality | HLT | Disease burden and mortality | vulnerability | % | COUNTRY | WB_WDI SH.DYN.NCOM.ZS SDG 3.4.1 WHO_GHO NCDMORT3070 |
結核罹患率IND.HLT.burden.tb_incidence | HLT | Disease burden and mortality | hazard | /10*5 | COUNTRY | WB_WDI SH.TBS.INCD SDG 3.3.2 WHO_GHO MDG_0000000020 |
マラリア罹患率IND.HLT.burden.malaria_incidence | HLT | Disease burden and mortality | hazard | /10*3 | COUNTRY | WB_WDI SH.MLR.INCD.P3 SDG 3.3.3 WHO_GHO SDGMALARIA |
HIV 罹患率IND.HLT.burden.hiv_incidence | HLT | Disease burden and mortality | hazard | /10*3 | COUNTRY | WB_WDI SH.HIV.INCD.TL.P3 SDG 3.3.1 WHO_GHO SDGHIV WB_WDI SH.HIV.INCD.ZS |
人口 1,000 人あたり医師数IND.HLT.system.physician_density | HLT | Health system capacity | coping capacity | /10*3 | COUNTRY | WB_WDI SH.MED.PHYS.ZS WHO_GHO HWF_0001 SDG 3.c.1 |
人口 1,000 人あたり看護師・助産師数IND.HLT.system.nurse_midwife_density | HLT | Health system capacity | coping capacity | /10*3 | COUNTRY | WB_WDI SH.MED.NUMW.P3 WHO_GHO HWF_0006 SDG 3.c.1 |
人口 1,000 人あたり病床数IND.HLT.system.hospital_beds | HLT | Health system capacity | coping capacity | /10*3 | COUNTRY | WB_WDI SH.MED.BEDS.ZS WHO_GHO WHS6_102 |
UHC サービス・カバレッジ指数IND.HLT.system.uhc_service_coverage | HLT | Health system capacity | coping capacity | {score} | COUNTRY | SDG 3.8.1 WHO_GHO UHC_INDEX_REPORTED WB_WDI SH.UHC.SRVS.CV.XD |
壊滅的な自己負担医療費を負う人口IND.HLT.system.catastrophic_oop | HLT | Health system capacity | vulnerability | % | COUNTRY | SDG 3.8.2 WB_WDI SH.UHC.OOPC.10.ZS |
自己負担支出(経常保健支出に占める割合)IND.HLT.system.oop_share | HLT | Health system capacity | vulnerability | % | COUNTRY | WB_WDI SH.XPD.OOPC.CH.ZS WHO_GHO GHED_OOPSCHE_SHA2011 |
経常保健支出(GDP 比)IND.HLT.system.health_expenditure.gdp | HLT | Health system capacity | coping capacity | % | COUNTRY | WB_WDI SH.XPD.CHEX.GD.ZS |
DTP3 予防接種率IND.HLT.system.dtp3_coverage | HLT | Health system capacity | coping capacity | % | COUNTRY | WHO_GHO WHS4_100 WB_WDI SH.IMM.IDPT SDG 3.b.1 |
麻疹ワクチン 2 回目接種率IND.HLT.system.mcv2_coverage | HLT | Health system capacity | coping capacity | % | COUNTRY | WHO_GHO MCV2 WB_WDI SH.IMM.MEA2 SDG 3.b.1 |
熟練した医療従事者が立ち会う出産IND.HLT.system.skilled_birth_attendance | HLT | Health system capacity | coping capacity | % | COUNTRY | WB_WDI SH.STA.BRTC.ZS SDG 3.1.2 |
最寄りの医療施設までの移動時間IND.HLT.system.health_facility_travel_time | HLT | Health system capacity | vulnerability | min | COUNTRY, ADM1, ADM2, CITY, GRID | |
IHR コア能力スコア(SPAR)IND.HLT.security.spar_capacity | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SDG 3.d.1 WHO_GHO SDGIHR2021 WHO_GHO SDGIHR2018 |
IHR 検査能力(SPAR C4)IND.HLT.security.spar_laboratory | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C4 WHO_GHO IHRSPAR2_C04 JEE D1 |
IHR サーベイランス能力(SPAR C5)IND.HLT.security.spar_surveillance | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C5 WHO_GHO IHRSPAR2_C05 JEE D2 |
IHR 健康危機管理能力(SPAR C7)IND.HLT.security.spar_emergency_management | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C7 WHO_GHO IHRSPAR2_C07 JEE R1 |
IHR リスク・コミュニケーション能力(SPAR C10)IND.HLT.security.spar_risk_communication | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C10 WHO_GHO IHRSPAR2_C10 JEE R5 |
感染症流行事象の頻度IND.HLT.epidemic.outbreak_event_frequency | HLT | Epidemic and outbreak | hazard | 1 | COUNTRY, ADM1 | |
報告されたコレラ症例(人口 100,000 人あたり)IND.HLT.epidemic.cholera_cases.p100k | HLT | Epidemic and outbreak | hazard | /10*5 | COUNTRY | WHO_GHO CHOLERA_0000000001 |
MRSA による血流感染IND.HLT.amr.mrsa_bloodstream | HLT | Antimicrobial resistance | hazard | % | COUNTRY | WHO_GHO AMR_INFECT_MRSA SDG 3.d.2 |
第 3 世代セファロスポリン耐性大腸菌(E. coli)による血流感染IND.HLT.amr.ecoli_3gc_bloodstream | HLT | Antimicrobial resistance | hazard | % | COUNTRY | WHO_GHO AMR_INFECT_ECOLI SDG 3.d.2 |
5 歳未満児の発育阻害IND.HLT.nutrition.stunting | HLT | Nutrition | vulnerability | % | COUNTRY | WB_WDI SH.STA.STNT.ME.ZS SDG 2.2.1 WHO_GHO NUTSTUNTINGPREV FAO_FAOSTAT 21025 |
5 歳未満児の消耗症IND.HLT.nutrition.wasting | HLT | Nutrition | vulnerability | % | COUNTRY, ADM1 | WB_WDI SH.STA.WAST.ZS SDG 2.2.2 WHO_GHO NUTRITION_WH_2 FAO_FAOSTAT 21026 |
妊娠可能年齢の女性の貧血IND.HLT.nutrition.anaemia_women | HLT | Nutrition | vulnerability | % | COUNTRY | WB_WDI SH.ANM.ALLW.ZS WHO_GHO NUTRITION_ANAEMIA_REPRODUCTIVEAGE_PREV SDG 2.2.3 FAO_FAOSTAT 21043 |
Health security risk index, world
The world reading of this index, every country as a tile and the largest movements since the previous edition.
- 前回の版
- –
- Range since 2016
- –
- 結合総合
- –
- 結合スコア S
- –
- パルス、直近 1 週間
- –
- Outlook, 12 months
- –
- 手法
- Indicator Standard 1.0 · NXS-GRX 2026
- 抽出
- 1,000
公開済みの値はまだありません。最初の版で、区間の帯と区分の境界とともに履歴がここに描かれます。
Country values
- タイル
/api/v1/public/grix/risk-products/tiles/hlt/{z}/{x}/{y}.mvt- 観測キー
nis:IDX.HLT.security.health_security_risk:{ISO3}:{YEAR}:A
Series that read this index
Crosswalks and validity checks
Crosswalks map leaf indicators to source code lists; established indices are used for validity checks, never re-weighted as inputs.
| Code system | Leaf indicators mapped |
|---|---|
WHO_GHO | 22 |
WB_WDI | 18 |
SDG | 17 |
SPAR | 4 |
JEE | 4 |
FAO_FAOSTAT | 3 |
Platforms, standards and ways to take part
Field and service platforms of GCRI, GRF and GRA, the Nexus Risk Standards for this domain, learning, working groups and open calls. Every link is a live page.
引用と再利用
See this index in every country profile
Each profile shows this index with its interval and class once released.
ステータス
The Global Risks Index の手法、構造、定義は準備段階の作業草案(2026 年)であり、レビューと意見募集のために配布されているもので、実施を目的としたものではありません。管理されたエビデンスの区切りから版が公表されるまで、値は一切表示されません。公表後の値には、区間、区分、出典、訂正の経路が付されます。シミュレーターは、公表された手法をあなたが選んだ数値で実行するものであり、NXS-GRX の値を表示することはありません。
NXS-GRX ではないもの
NXS-GRX は研究およびリスク分析の情報です。信用格付や ESG 格付ではなく、格付尺度を用いず、金融商品のベンチマークでも、公的統計でも、緊急警報や公式分類でも、助言でもありません。自然人の評価に用いてはなりません。リスククラスは公開された尺度上の区分であり、国や人の順位付けではありません。
機関と情報源
The Nexus Consortium is stewarded by three independent not-for-profit institutions: The Global Centre for Risk and Innovation (GCRI), through GCRI US in Washington, DC and GCRI Canada in Ontario, with GCRI Canada as Lead Institution, Consortium Secretariat and lead contracting organisation; The Global Risks Forum (GRF); and The Global Risks Alliance (GRA). Technology, infrastructure and service providers work with the Consortium at arm’s length under written agreements, like every other external party in the public-private-planet model, and hold no role in its stewardship.
すべての値には情報源の帰属表示が付され、情報源はそれぞれ独自のライセンスを保持します。外部の名称は相互運用性のためにのみ引用しています。Nexus が執筆したテキストは、公開時に CC BY 4.0 とする予定です。
Avis en français
La méthodologie et les définitions du NXS-GRX sont un projet de travail préparatoire (2026). Le NXS-GRX est une information de recherche et d’analyse des risques : ni notation, ni indice de référence financier, ni statistique officielle, ni alerte, ni conseil. Les classes de risque sont des bandes sur une échelle publiée, non des classements.